Tesla
TSLA
NVIDIA
NVDA
Palantir
PLTR
4
Apple
AAPL
5
Gorilla Technology
GRRR
US Stock MarketDetailed Quotes
BHC Bausch Health
- 7.000
- 0.0000.00%
Close Mar 11 16:00 ET
- 7.000
- 0.0000.00%
Post 18:38 ET
2.58BMarket Cap-53.85P/E (TTM)
7.065High6.930Low694.74KVolume6.970Open7.000Pre Close4.86MTurnover0.25%Turnover RatioLossP/E (Static)367.93MShares11.46052wk High-2.01P/B1.93BFloat Cap3.96052wk Low--Dividend TTM275.24MShs Float34.800Historical High--Div YieldTTM1.93%Amplitude3.960Historical Low6.999Avg Price1Lot Size
Bausch Health Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 54.75%1.6B | 54.10%601M | 43.62%405M | 84.47%380M | 37.01%211M | 241.76%1.03B | -17.89%390M | 122.33%282M | 67.48%206M | 344.44%154M |
| Net income from continuing operations | 88.22%-72M | 308.51%98M | 75.92%-92M | -103.70%-1M | 63.16%-77M | -188.21%-611M | 88.54%-47M | -194.79%-382M | 119.42%27M | -216.67%-209M |
| Operating gains losses | -279.17%-43M | 106.25%33M | -200.00%-24M | -314.29%-30M | -1,200.00%-22M | 102.72%24M | 108.29%16M | 98.61%-8M | 112.28%14M | 200.00%2M |
| Depreciation and amortization | 0.24%1.27B | -6.69%307M | 6.98%322M | 0.95%318M | 0.31%320M | -9.33%1.26B | -8.61%329M | -10.15%301M | -9.22%315M | -9.38%319M |
| Deferred tax | 29.41%66M | 102.38%170M | 0.00%-3M | -46.67%-44M | ---57M | 128.98%51M | 342.11%84M | 96.88%-3M | -87.50%-30M | --0 |
| Other non cash items | -13.25%131M | -46.67%24M | -64.47%27M | 622.22%47M | -15.38%33M | 110.27%151M | -8.16%45M | 106.17%76M | -119.57%-9M | 111.68%39M |
| Change In working capital | 101.20%7M | 31.76%-116M | 185.14%126M | 115.76%32M | 42.62%-35M | -46.97%-582M | -672.73%-170M | 44.98%-148M | -67.77%-203M | -481.25%-61M |
| -Change in receivables | -10.77%-216M | -447.37%-104M | 109.96%23M | -35.85%-72M | -158.33%-63M | -242.11%-195M | 38.71%-19M | -73.68%-231M | 41.11%-53M | -45.18%108M |
| -Change in inventory | 17.08%-267M | 51.00%-49M | 32.26%-42M | 0.00%-32M | -12.50%-144M | -62.63%-322M | -2,400.00%-100M | -10.71%-62M | 50.77%-32M | -75.34%-128M |
| -Change in prepaid assets | 159.64%133M | 108.78%13M | 104.76%1M | 90.48%-2M | 466.67%121M | -237.88%-223M | -335.29%-148M | -231.25%-21M | -40.00%-21M | 0.00%-33M |
| -Change in payables and accrued expense | 125.95%357M | -75.26%24M | -13.25%144M | 242.27%138M | 737.50%51M | 310.67%158M | 106.38%97M | 272.92%166M | -297.96%-97M | 89.33%-8M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 54.75%1.6B | 54.10%601M | 43.62%405M | 84.47%380M | 37.01%211M | 241.76%1.03B | -17.89%390M | 122.33%282M | 67.48%206M | 344.44%154M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 78.83%-454M | -35.14%-200M | 94.60%-102M | -163.33%-79M | 6.41%-73M | -607.92%-2.15B | -8.82%-148M | -3,464.15%-1.89B | 48.28%-30M | -39.29%-78M |
| Net PPE purchase and sale | -56.74%-337M | -8.16%-106M | -69.05%-71M | -178.57%-78M | -74.47%-82M | 1.38%-215M | -48.48%-98M | 22.22%-42M | 46.15%-28M | -2.17%-47M |
| Net intangibles purchase and sale | 94.74%-3M | 97.83%-1M | --0 | 66.67%-1M | 75.00%-1M | -14.00%-57M | -53.33%-46M | 20.00%-4M | 25.00%-3M | 63.64%-4M |
| Net business purchase and sale | 92.80%-136M | -2,933.33%-91M | 97.58%-45M | --0 | --0 | -4,100.00%-1.89B | 93.33%-3M | ---1.86B | --0 | ---31M |
| Net investment purchase and sale | 300.00%2M | -100.00%-2M | 0.00%2M | ---1M | 250.00%3M | -120.00%-1M | ---1M | -66.67%2M | --0 | -300.00%-2M |
| Net other investing changes | 40.00%7M | --0 | 25.00%5M | --1M | --1M | 0.00%5M | --0 | --4M | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 78.83%-454M | -35.14%-200M | 94.60%-102M | -163.33%-79M | 6.41%-73M | -607.92%-2.15B | -8.82%-148M | -3,464.15%-1.89B | 48.28%-30M | -39.29%-78M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -158.85%-868M | 207.59%85M | -110.41%-189M | -253.33%-424M | -139.44%-340M | 411.18%1.48B | 71.38%-79M | 5,144.44%1.82B | 80.95%-120M | -130.34%-142M |
| Net issuance payments of debt | -150.54%-799M | 266.67%95M | -108.76%-164M | -273.87%-415M | -154.03%-315M | 256.53%1.58B | 78.65%-57M | 9,265.00%1.87B | 91.22%-111M | -124.75%-124M |
| Net common stock issuance | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash dividends paid | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 |
| Net other financing activities | 34.91%-69M | 70.69%-17M | 14.29%-18M | -44.44%-13M | -16.67%-21M | 23.74%-106M | 27.50%-58M | -240.00%-21M | 78.05%-9M | 45.45%-18M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -158.85%-868M | 207.59%85M | -110.41%-189M | -253.33%-424M | -139.44%-340M | 411.18%1.48B | 71.38%-79M | 5,144.44%1.82B | 80.95%-120M | -130.34%-142M |
| Net cash flow | ||||||||||
| Beginning cash position | 62.77%962M | -3.85%750M | 5.95%623M | 42.18%755M | 62.77%962M | -72.11%591M | 56.94%780M | -68.71%588M | -78.41%531M | -72.11%591M |
| Current changes in cash | -24.03%275M | 198.16%486M | -45.45%114M | -319.64%-123M | -206.06%-202M | 124.05%362M | 158.73%163M | 115.46%209M | 109.91%56M | -118.91%-66M |
| Effect of exchange rate changes | -500.00%-36M | -284.21%-35M | 176.47%13M | -1,000.00%-9M | -183.33%-5M | 139.13%9M | -38.71%19M | 43.33%-17M | 106.25%1M | 175.00%6M |
| End cash Position | 24.84%1.2B | 24.84%1.2B | -3.85%750M | 5.95%623M | 42.18%755M | 62.77%962M | 62.77%962M | 56.94%780M | -68.71%588M | -78.41%531M |
| Free cash flow | 65.39%1.26B | 100.81%494M | 41.53%334M | 72.00%301M | 24.27%128M | 176.31%760M | -35.09%246M | 117.85%236M | 161.19%175M | 185.83%103M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |